Related Experiment Videos

Continuous ambulatory peritoneal dialysis. Three years' experience at the Mayo Clinic

Mayo Clinic Proceedings
|October 1, 1983
PubMed

Insights

Continuous ambulatory peritoneal dialysis offers adequate short-term treatment for end-stage renal failure patients. While metabolic and technical issues exist, most patients find this therapy a viable alternative to hemodialysis.

Area of Science:

  • Nephrology
  • Internal Medicine

Background:

  • End-stage renal failure (ESRF) necessitates renal replacement therapy.
  • Continuous ambulatory peritoneal dialysis (CAPD) is an alternative to hemodialysis.

Purpose of the Study:

  • To evaluate the efficacy and patient acceptance of CAPD in ESRF patients.
  • To identify metabolic and technical challenges associated with CAPD.

Main Methods:

  • Prospective study of 69 ESRF patients treated with CAPD from 1979-1982.
  • Assessment of dialysis adequacy, ultrafiltration, hemoglobin levels, and patient outcomes.

Main Results:

  • CAPD was adequate and stable in 65 out of 69 patients.
  • Metabolic issues included hyperparathyroidism, nutrition, neuropathy, and weight gain.
  • Technical problems involved peritonitis, access, and hernias.

Conclusions:

  • CAPD provides adequate short-term treatment for most ESRF patients.
  • Patient enthusiasm remained high despite challenges.
  • Long-term CAPD potential requires further investigation.

Related Concept Videos